Tag: TAK-003
Takeda gets QDENGA EC approval as dengue vaccine
Takeda has received the European Commission’s (EC) marketing authorization for the company’s dengue vaccine QDENGA (Dengue Tetravalent Vaccine ) (TAK-003). The QDENGA vaccine is indicated ... Read More
Takeda Pharmaceutical opens €130m vaccine manufacturing plant in Germany
Takeda Pharmaceutical Company opened a new €130 million vaccine manufacturing plant in Germany at Singen to produce TAK-003, its dengue vaccine candidate. The Singen vaccine ... Read More